B. Liu

4O: Amivantamab plus lazertinib vs osimertinib in first-line (1L) EGFR-mutant (EGFRm) advanced NSCLC: Final overall survival (OS) from the phase III MARIPOSA study

OA02.05 Lazertinib vs Osimertinib in 1L EGFR-Mutant Advanced NSCLC: A Randomized, Double-Blind, Exploratory Analysis from MARIPOSA

133P The efficacy and safety of KN046 combined with axitinib for previously untreated and checkpoint inhibitor treated advanced non-small cell lung cancer: A single-arm, open-label, multicenter phase II clinical trial

Measurement of the photon beam asymmetry in <mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML"><mml:mrow><mml:mover accent="true"><mml:mi>γ</mml:mi><mml:mo></mml:mo></mml:mover><mml:mi>p</mml:mi><mml:mo>→</mml:mo><mml:msup><mml:mi>K</mml:mi><mml:mo>+</mml:mo></mml:msup><mml:msup><mml:mi mathvariant="normal">Σ</mml:mi><mml:mn>0</mml:mn></mml:msup></mml:mrow></mml:math> at <mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML"><mml:mrow><mml:msub><mml:mi>E</mml:mi><mml:mi>γ</mml:mi></mml:m

Beam asymmetry <mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML"><mml:mi mathvariant="normal">Σ</mml:mi></mml:math> for the photoproduction of <mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML"><mml:mi>η</mml:mi></mml:math> and <mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML"><mml:msup><mml:mi>η</mml:mi><mml:mo>′</mml:mo></mml:msup></mml:math> mesons at <mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML"><mml:mrow><mml:msub><mml:mi>E</mml:mi><mml:mi>γ</mml:mi></mml:msub